| scholarly article | Q13442814 |
| P356 | DOI | 10.5588/09640569513011 |
| P698 | PubMed publication ID | 12068983 |
| P2093 | author name string | A E Bulpitt | |
| C A Peloquin | |||
| J J Stambaugh | |||
| S E Berning | |||
| M Narita | |||
| D Ashkin | |||
| E S Hollender | |||
| P433 | issue | 6 | |
| P921 | main subject | tuberculosis | Q12204 |
| pharmacokinetics | Q323936 | ||
| levofloxacin | Q424193 | ||
| P304 | page(s) | 503-509 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | International Journal of Tuberculosis and Lung Disease | Q15767020 |
| P1476 | title | Ofloxacin population pharmacokinetics in patients with tuberculosis | |
| P478 | volume | 6 |
| Q38533435 | Antituberculosis drugs in children |
| Q38386834 | Fluoroquinolones for the treatment of tuberculosis in children. |
| Q43060441 | Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs |
| Q36137356 | Levofloxacin pharmacokinetics in adult cystic fibrosis |
| Q37544479 | Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients |
| Q36075800 | Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis. |
| Q37712966 | Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children. |
| Q36086373 | Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis |
| Q36482760 | Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis |
| Q28535115 | Resistance of M. leprae to quinolones: a question of relativity? |
| Q42281128 | Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. |
Search more.